Paper23967302
Expression of galectin-7 is induced in breast cancer cells by mutant p53.
Campion CG and 3 others. PLoS One, 2013. Cited by 38 papers, by iCite.
Cite this record
ConductScience Library. Expression of galectin-7 is induced in breast cancer cells by mutant p53. Papers, record 23967302. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23967302
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Galectins | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| Mutation | Major topic |
| Transcriptional Activation | Major topic |
| Tumor Suppressor Protein p53 | Major topic |
| Animals | |
| Cell Line, Tumor | |
| Humans | |
| NF-kappa B | |
| Up-Regulation |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| MOP-89697 | Canadian Institutes of Health Research | Canada | PubMed |
Source PubMed
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9697310 | Galectin-7, a marker of all types of stratified epithelia. | Differentiation | 1998 | https://conductscience.org/library/papers/9697310 | PubMed |
| 2 | 20190799 | Cross talk between stimulated NF-kappaB and the tumor suppressor p53. | Oncogene | 2010 | https://conductscience.org/library/papers/20190799 | PubMed |
| 3 | 10713666 | Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy. | Oncogene | 2000 | https://conductscience.org/library/papers/10713666 | PubMed |
| 4 | 18829868 | Galectin-7 in the control of epidermal homeostasis after injury. | Mol Biol Cell | 2008 | https://conductscience.org/library/papers/18829868 | PubMed |
| 5 | 20177845 | CD24 and galectin-1 expressions in gastric adenocarcinoma and clinicopathologic significance. | Pathol Oncol Res | 2010 | https://conductscience.org/library/papers/20177845 | PubMed |
| 6 | 11706006 | Galectin-7 (PIG1) exhibits pro-apoptotic function through JNK activation and mitochondrial cytochrome c release. | J Biol Chem | 2002 | https://conductscience.org/library/papers/11706006 | PubMed |
| 7 | 22961650 | Characterization of proteins secreted by pancreatic cancer cells with anticancer drug treatment in vitro. | Oncol Rep | 2012 | https://conductscience.org/library/papers/22961650 | PubMed |
| 8 | 11910072 | A system for stable expression of short interfering RNAs in mammalian cells. | Science | 2002 | https://conductscience.org/library/papers/11910072 | PubMed |
| 9 | 15630413 | Galectins as modulators of tumour progression. | Nat Rev Cancer | 2005 | https://conductscience.org/library/papers/15630413 | PubMed |
| 10 | 18584353 | Identification of galectin-3 and mucin-type O-glycans in breast cancer and its metastasis to brain. | Cancer Invest | 2008 | https://conductscience.org/library/papers/18584353 | PubMed |
| 11 | 22201754 | A distinctive role for galectin-7 in cancer ? | Front Biosci (Landmark Ed) | 2012 | https://conductscience.org/library/papers/22201754 | PubMed |
| 12 | 20596638 | Identification of Galectin-1 as a novel biomarker in nasopharyngeal carcinoma by proteomic analysis. | Oncol Rep | 2010 | https://conductscience.org/library/papers/20596638 | PubMed |
| 13 | 21289092 | Mitochondrial proteomic approach reveals galectin-7 as a novel BCL-2 binding protein in human cells. | Mol Biol Cell | 2011 | https://conductscience.org/library/papers/21289092 | PubMed |
| 14 | 10500176 | Galectin-7 overexpression is associated with the apoptotic process in UVB-induced sunburn keratinocytes. | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/10500176 | PubMed |
| 15 | 18315601 | Increased expression and altered intracellular distribution of adhesion/growth-regulatory lectins galectins-1 and -7 during tumour progression in hypopharyngeal and laryngeal squamous cell carcinomas. | Histopathology | 2008 | https://conductscience.org/library/papers/18315601 | PubMed |
| 16 | 10963602 | Molecular portraits of human breast tumours. | Nature | 2000 | https://conductscience.org/library/papers/10963602 | PubMed |
| 17 | 8799159 | Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. | Proc Natl Acad Sci U S A | 1996 | https://conductscience.org/library/papers/8799159 | PubMed |
| 18 | 14689585 | Galectins and urological cancer. | J Cell Biochem | 2004 | https://conductscience.org/library/papers/14689585 | PubMed |
| 19 | 9679965 | Galectin-3 is a presurgical marker of human thyroid carcinoma. | Cancer Res | 1998 | https://conductscience.org/library/papers/9679965 | PubMed |
| 20 | 20382700 | Overexpression of galectin-7, a myoepithelial cell marker, enhances spontaneous metastasis of breast cancer cells. | Am J Pathol | 2010 | https://conductscience.org/library/papers/20382700 | PubMed |
Cited by32
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41700699 | Network-based allosteric analysis of galectin-7: Key residues dictate functional communication and stability. | Protein Sci | 2026 | https://conductscience.org/library/papers/41700699 | PubMed |
| 41319388 | Galectin-7 as a biomarker for aggressiveness and poor prognosis in thymic epithelial tumors. | Transl Oncol | 2026 | https://conductscience.org/library/papers/41319388 | PubMed |
| 40134029 | Multifaceted roles of Galectins: from carbohydrate binding to targeted cancer therapy. | Biomark Res | 2025 | https://conductscience.org/library/papers/40134029 | PubMed |
| 39122742 | Adipsin-dependent adipocyte maturation induces cancer cell invasion in breast cancer. | Sci Rep | 2024 | https://conductscience.org/library/papers/39122742 | PubMed |
| 38927753 | Correlation Analysis of Genetic Mutations and Galectin Levels in Breast Cancer Patients. | Genes (Basel) | 2024 | https://conductscience.org/library/papers/38927753 | PubMed |
| 37224225 | Non-muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-Guérin. | Sci Transl Med | 2023 | https://conductscience.org/library/papers/37224225 | PubMed |
| 36817445 | Galectins as pivotal components in oncogenesis and immune exclusion in human malignancies. | Front Immunol | 2023 | https://conductscience.org/library/papers/36817445 | PubMed |
| 36766779 | Placental Galectins in Cancer: Why We Should Pay More Attention. | Cells | 2023 | https://conductscience.org/library/papers/36766779 | PubMed |
| 36693903 | Galectin-7 reprograms skin carcinogenesis by fostering innate immune evasive programs. | Cell Death Differ | 2023 | https://conductscience.org/library/papers/36693903 | PubMed |
| 36364232 | Pectin: A Bioactive Food Polysaccharide with Cancer Preventive Potential. | Molecules | 2022 | https://conductscience.org/library/papers/36364232 | PubMed |
| 35686268 | An Update to Hallmarks of Cancer. | Cureus | 2022 | https://conductscience.org/library/papers/35686268 | PubMed |
| 35681762 | KIT Mutations Correlate with Higher Galectin Levels and Brain Metastasis in Breast and Non-Small Cell Lung Cancer. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35681762 | PubMed |
| 34638303 | Increased Circulating Levels of Galectin Proteins in Patients with Breast, Colon, and Lung Cancer. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34638303 | PubMed |
| 34198494 | Towards a Better Understanding of the Relationships between Galectin-7, p53 and MMP-9 during Cancer Progression. | Biomolecules | 2021 | https://conductscience.org/library/papers/34198494 | PubMed |
| 34152508 | Imitating evolution's tinkering by protein engineering reveals extension of human galectin-7 activity. | Histochem Cell Biol | 2021 | https://conductscience.org/library/papers/34152508 | PubMed |
| 33185768 | The Dysregulated Galectin Network Activates NF-κB to Induce Disease Markers and Matrix Degeneration in 3D Pellet Cultures of Osteoarthritic Chondrocytes. | Calcif Tissue Int | 2021 | https://conductscience.org/library/papers/33185768 | PubMed |
| 32766716 | Pro4 prolyl peptide bond isomerization in human galectin-7 modulates the monomer-dimer equilibrum to affect function. | Biochem J | 2020 | https://conductscience.org/library/papers/32766716 | PubMed |
| 32290551 | High Galectin-7 and Low Galectin-8 Expression and the Combination of both are Negative Prognosticators for Breast Cancer Patients. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32290551 | PubMed |
| 31873723 | Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression. | J Exp Med | 2020 | https://conductscience.org/library/papers/31873723 | PubMed |
| 30250540 | Galectin-7 is elevated in endometrioid (type I) endometrial cancer and promotes cell migration. | Oncol Lett | 2018 | https://conductscience.org/library/papers/30250540 | PubMed |
Genes14
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23967302
GET https://conductscience.org/api/papers/v1/23967302/references?page=2